MARCOUXMED
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
01-07
micro format · 30 days before the deadline
2025
31-12
Financial
Highest result from 2023 to 2025net €222,039 ▲73.7%
The operating result of €349,439 and the net result of €222,039 are both a record.
31-12
Financial
Liquidity more than 27 timescurrent ratio 158.07
The current ratio rises from 5.65 to 158.07. Short-term debt falls from €56,766 to €2,921.
31-12
Financial
Equity above €200,000equity €410,309 ▲118%
With a profit in every financial year since 2023, equity grows to €410,309.
30-07
micro format · 1 day before the deadline
2024
31-12
Financial
Equity above €150,000equity €188,270 ▲211%
With a profit in every financial year since 2023, equity grows to €188,270.
17-07
micro format · 14 days before the deadline
2023
31-01
Gazette deed
IncorporationStarting capital €2,000 · Appointment: MARCOUX Diane (director) · Registered office clause · Board rule10 points ▸
Gazette deed
Incorporation
Starting capital €2,000 · Appointment: MARCOUX Diane (director) · Registered office clause · Board rule10 points ▸
- Registered office clause, “1. Adresse du siège, 6230 Pont-à-Celles,Chaussée de Nivelles,716” (deed in French)
- Other provision, “2. Adresse électronique, toute communication vers cette adresse par actionnaires,titulaires de titres et titulaires de certificats réputée intervenue valablemen…” (deed in French)
- Board rule, “4. Administrateur non statutaire”, 1 (deed in French)
- Director appointment, MARCOUX Diane (director)
- Other provision, “7. Représentant permanent, représentant permanent” (deed in French)
- Pre-incorporation commitments, “8. Reprise des engagements, takeover” (deed in French)
- Incorporation, “MARCOUXMED” (deed in French)
- Founder, MARCOUX Diane
- Founding capital, €2,000
- Capital
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank